UK to leverage Amazon Alexa for medical advice

U.K. residents will soon be able to utilize their Amazon Alexa voice technology to get certain medical information, after the National Health Service (NHS) struck a partnership with Amazon.

The collaboration uses Amazon’s algorithm and information from the NHS website to answer questions like, “Alexa, what are the symptoms of the flu?” according to NHS. The partnership reflects the growing use of voice technology devices. According to NHS, half of all searches are expected to be made through voice-assisted technology.

“The public need to be able to get reliable information about their health easily and in ways they actually use,” Matthew Gould, chief executive of NHSX, said in a statement. “By working closely with Amazon and other tech companies, big and small, we can ensure that the millions of users looking for health information every day can get simple, validated advice at the touch of a button or voice command.”

While Amazon scored the partnership, Google’s voice technology actually performed better than its peers, including Amazon and Apple’s Siri voice assistants, in a recent study. The emergence of voice technology has prompted many medical uses, with even the potential to detect a range of mental and physical ailments of a person just from hearing their voice.

NHSX, a unit of NHS, plans to look for ways to make NHS services more available to all patients with digital technology. It will also potentially partner with other technology providers on similar services, according to CNN Business.

“We want to empower every patient to take better control of their healthcare and technology like this is a great example of how people can access reliable, world-leading NHS advice from the comfort of their home, reducing the pressure on our hardworking GPs and pharmacists,” Secretary of State for Health and Social Care Matt Hancock said in a statement.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.